* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Duetact (pioglitazone/glimepiride) is a prescription medication used to help adults with type 2 diabetes mellitus manage their blood sugar levels.
Type 2 diabetes is a long-term condition that occurs when your body does not respond properly to insulin or cannot produce enough insulin to keep your blood sugar within a healthy range.
Insulin is a hormone produced by your pancreas that helps glucose (sugar) move from your bloodstream into your body’s cells, where it is used for energy. When insulin does not work effectively, glucose builds up in your blood, causing high blood sugar levels.
Duetact contains two active ingredients that work together to improve blood sugar control. Pioglitazone helps your body use insulin more effectively, while glimepiride helps your pancreas release more insulin.
Your healthcare provider may prescribe Duetact to help manage the following condition:
Duetact is generally prescribed when treatment with both pioglitazone and glimepiride is appropriate. Combining these medications into a single tablet may make treatment more convenient for some patients.
Duetact is intended to be used alongside healthy lifestyle habits, including balanced meals, regular physical activity, and blood sugar monitoring.
It helps manage type 2 diabetes but does not permanently cure the condition.
Important: Duetact is not used to treat type 1 diabetes or diabetic ketoacidosis. It also carries important risks, including low blood sugar and fluid retention, which may worsen or cause heart failure in susceptible patients.
Duetact contains two active ingredients: pioglitazone and glimepiride. These medications belong to different classes of diabetes treatments and work in complementary ways to help lower blood sugar.
In people with type 2 diabetes, blood sugar may remain elevated because the body does not respond effectively to insulin or because the pancreas does not release enough insulin.
Duetact addresses both problems by improving how the body responds to insulin and increasing the amount of insulin released by the pancreas.
Pioglitazone: Helps Your Body Use Insulin More Effectively
Pioglitazone belongs to a group of medications called thiazolidinediones (TZDs).
It works by improving insulin sensitivity, which means it helps your body’s cells respond more effectively to the insulin already present in your bloodstream.
When your muscles and fat cells respond better to insulin, they can take up and use glucose more efficiently. Pioglitazone also helps reduce the amount of glucose released by your liver.
Pioglitazone helps to:
Pioglitazone does not directly stimulate your pancreas to release additional insulin. Instead, it helps your body use existing insulin more effectively.
Its full blood sugar-lowering effects may take several weeks to develop.
Glimepiride: Helps Your Pancreas Release More Insulin
Glimepiride belongs to a group of medications called sulfonylureas.
It works by stimulating specialized cells in your pancreas, called beta cells, to release insulin.
Insulin helps glucose move from your bloodstream into your body’s cells, where it can be used for energy.
Glimepiride helps to:
Because glimepiride increases insulin release, it can sometimes cause blood sugar to fall too low. This is called hypoglycemia.
Symptoms of low blood sugar may include shakiness, sweating, dizziness, hunger, headache, confusion, or a fast heartbeat.
Your healthcare provider may recommend regular blood sugar monitoring, especially when starting treatment or adjusting your dose.
How Do the Two Ingredients Work Together?
Duetact combines two medications that target different causes of high blood sugar in people with type 2 diabetes.
Pioglitazone helps your body respond better to insulin, while glimepiride helps your pancreas release more insulin.
Together, these ingredients help improve blood sugar control more effectively for some patients than either medication alone.
The combination may help:
Duetact is usually taken once daily with the first main meal of the day, as directed by your healthcare provider.
Your healthcare provider will determine the appropriate dose based on your current diabetes medications, blood sugar levels, and response to treatment.
Duetact is intended for adults with type 2 diabetes who need treatment with both pioglitazone and glimepiride. It should be taken exactly as prescribed and used alongside a balanced diet, physical activity, and regular blood sugar monitoring.
The medication is generally taken once daily with the first main meal of the day. Taking it with food helps reduce the risk of low blood sugar associated with glimepiride.
Duetact may not be suitable for everyone. In particular, pioglitazone can cause fluid retention and may cause or worsen congestive heart failure. Contact your healthcare provider promptly if you experience rapid weight gain, swelling in your legs or ankles, or unusual shortness of breath.
Because glimepiride can cause hypoglycemia, it is important to recognize symptoms such as sweating, shaking, dizziness, sudden hunger, and confusion.
Your healthcare provider may recommend regular blood sugar testing and HbA1c tests to monitor how well Duetact is controlling your diabetes.
Do not stop taking Duetact or change your dosage without consulting your healthcare provider.
Duetact helps manage type 2 diabetes by improving insulin sensitivity and increasing insulin release. When used as part of a comprehensive diabetes management plan, it can help maintain healthier blood sugar levels and reduce the risk of complications associated with uncontrolled diabetes.
Duetact is a prescription medication taken by mouth to help adults with type 2 diabetes manage their blood sugar levels.
Duetact contains two active ingredients that work together to improve blood sugar control. Pioglitazone helps your body use insulin more effectively, while glimepiride stimulates your pancreas to release more insulin.
Duetact is usually taken once daily with the first main meal of the day, typically breakfast. Taking the medication with food helps reduce the risk of low blood sugar, also known as hypoglycemia.
Your healthcare provider will determine the appropriate dose based on your blood sugar levels, medical history, current medications, and response to treatment.
The recommended dosage of Duetact varies depending on your individual treatment needs and whether you have previously taken pioglitazone, glimepiride, or other diabetes medications.
Duetact is available in the following tablet strengths:
| Tablet Strength | Pioglitazone | Glimepiride |
| Duetact 30 mg/2 mg | 30 mg | 2 mg |
| Duetact 30 mg/4 mg | 30 mg | 4 mg |
Treatment may begin with one tablet of Duetact 30 mg/2 mg or 30 mg/4 mg once daily, depending on your existing diabetes treatment and your healthcare provider’s assessment.
Your healthcare provider may adjust your dose gradually based on how well your blood sugar is controlled and whether you experience side effects.
Important: The 15 mg pioglitazone/1 mg glimepiride starting dose mentioned in the original text is not an available Duetact tablet strength under current U.S. prescribing information. The approved strengths are 30 mg/2 mg and 30 mg/4 mg.
Do not change your dose or take additional tablets without consulting your healthcare provider.
Follow these steps to take Duetact safely and correctly:
Take Duetact Regularly
Duetact works best when taken consistently as part of your daily diabetes management routine.
Even if your blood sugar readings improve or you feel well, continue taking the medication exactly as prescribed.
Stopping Duetact without medical advice may cause your blood sugar levels to rise again.
If you have difficulty remembering your medication, consider taking it with breakfast every day or setting a daily reminder.
Monitor Your Blood Sugar Levels
Regular blood sugar monitoring is an important part of managing type 2 diabetes while taking Duetact.
Glimepiride helps lower blood sugar by increasing insulin release, while pioglitazone improves your body’s response to insulin.
Your healthcare provider may recommend checking your blood sugar at specific times of the day, depending on your treatment plan.
They may also order an HbA1c blood test periodically to assess your average blood sugar levels over approximately three months.
Keep a record of your blood sugar readings and inform your healthcare provider if you notice frequent high or low readings.
Be Aware of Low Blood Sugar
Duetact contains glimepiride, which can cause your blood sugar to fall too low.
This condition is called hypoglycemia and may occur if you skip meals, eat less than usual, exercise more than expected, or take certain other diabetes medications.
Common symptoms of low blood sugar include:
If your blood sugar is below 4.0 mmol/L (70 mg/dL), and you can safely swallow, take approximately 15 grams of fast-acting carbohydrates, such as glucose tablets or regular fruit juice. Check your blood sugar again after 15 minutes and repeat if it remains low.
If you experience severe confusion, seizures, or loss of consciousness, emergency medical assistance is required. Do not give food or drink to someone who is unconscious.
Contact your healthcare provider if you experience frequent episodes of low blood sugar.
Allow Time for the Medication to Work
Duetact contains two medications that work differently to lower blood sugar.
Glimepiride begins helping your pancreas release insulin relatively soon after taking a dose.
Pioglitazone works more gradually by improving your body’s sensitivity to insulin. Its full blood sugar-lowering effect may take several weeks to a few months.
As a result, you may notice changes in your blood sugar readings before the medication reaches its maximum benefit.
Continue taking Duetact as prescribed and monitor your blood sugar regularly.
If your readings remain consistently above your recommended target, contact your healthcare provider rather than increasing your dose on your own.
Be Careful When Switching Diabetes Medications
If you are switching to Duetact from separate pioglitazone and glimepiride tablets or from another diabetes medication, follow your healthcare provider’s instructions carefully.
Your new dose may depend on the medications and strengths you were previously taking.
When switching from another sulfonylurea medication, such as glyburide or glipizide, there may be an increased risk of low blood sugar during the transition.
Your healthcare provider may recommend more frequent blood sugar monitoring during the first one to two weeks after switching treatments.
Do not continue taking your previous diabetes medication unless your healthcare provider specifically instructs you to do so.
Taking Duetact With Colesevelam
If you take colesevelam, a medication sometimes prescribed to lower cholesterol or help manage blood sugar, tell your healthcare provider or pharmacist before starting Duetact.
Colesevelam can reduce the absorption of glimepiride, one of the active ingredients in Duetact. This may affect how well the medication controls your blood sugar.
To reduce this interaction, take Duetact at least four hours before colesevelam.
For example, if you take Duetact with breakfast at 8:00 AM, you should wait until at least 12:00 PM before taking colesevelam.
Your healthcare provider or pharmacist can help you create a medication schedule that works with your meals and other treatments.
If you forget to take Duetact, follow the missed-dose instructions provided by your pharmacist or healthcare provider.
Do not take two tablets at once or double your next dose to make up for a missed tablet.
Taking extra Duetact may increase your risk of low blood sugar and other side effects.
If you are unsure whether to take a missed dose, contact your pharmacist for advice.
Duetact may cause fluid retention, swelling, and weight gain because it contains pioglitazone.
In some people, fluid retention can cause or worsen heart failure. Contact your healthcare provider promptly if you notice rapid weight gain, swelling in your legs or ankles, or increased shortness of breath.
Tell your healthcare provider if you have a history of heart failure, liver disease, kidney problems, or frequent low blood sugar episodes.
Your healthcare provider may recommend regular medical appointments and laboratory tests to monitor your response to treatment.
Contact your healthcare provider if your blood sugar remains consistently higher or lower than your recommended target, if you experience frequent hypoglycemia, or if you develop unusual side effects while taking Duetact.
You should also seek medical advice if you experience persistent dizziness, unusual weakness, rapid weight gain, swelling in your legs, or worsening shortness of breath.
Seek emergency medical attention if you experience severe difficulty breathing, chest pain, loss of consciousness, or symptoms of severe low blood sugar that cannot be safely treated at home.
Always take Duetact exactly as prescribed. Taking your medication once daily with your first main meal, monitoring your blood sugar regularly, and following your diabetes management plan can help improve blood sugar control while reducing the risk of complications.
Duetact (pioglitazone/glimepiride) is available in the following forms and strength:
Before taking Duetact, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.
Duetact is a prescription medication used to help adults with type 2 diabetes control their blood sugar levels. It contains two active ingredients that work together to improve insulin sensitivity and increase insulin release.
Although Duetact can help manage blood sugar, it may cause serious side effects in some people, including low blood sugar, fluid retention, and worsening heart failure.
Your healthcare provider may recommend regular blood tests, blood sugar monitoring, and medical appointments to make sure the medication is working safely.
Duetact can cause low blood sugar, also called hypoglycemia, because it contains glimepiride, a medication that stimulates your pancreas to release insulin.
The risk of low blood sugar may increase if you take Duetact with insulin or certain other diabetes medications. It may also occur if you skip meals, eat less than usual, exercise more than expected, or drink alcohol without eating enough food.
Common symptoms of low blood sugar include:
If your blood sugar falls below 4.0 mmol/L (70 mg/dL) and you can safely swallow, take approximately 15 grams of fast-acting carbohydrates, such as glucose tablets, regular juice, or regular soda.
Check your blood sugar again after 15 minutes. If it remains low, repeat the treatment.
Always carry glucose tablets or another fast-acting source of sugar in case your blood sugar drops unexpectedly.
If you experience severe confusion, seizures, or loss of consciousness, emergency medical assistance is required. Do not give food or drink to someone who is unconscious.
Contact your healthcare provider if you experience frequent episodes of low blood sugar. Your treatment plan or medication dosage may need to be adjusted.
Duetact contains pioglitazone, which can cause fluid retention and may lead to or worsen congestive heart failure.
Heart failure occurs when your heart cannot pump blood efficiently enough to meet your body’s needs. Fluid may build up in your lungs, legs, and other parts of your body.
Duetact carries a boxed warning about congestive heart failure. It should not be started in patients with established New York Heart Association (NYHA) Class III or IV heart failure.
Tell your healthcare provider if you have a history of heart failure, heart disease, or other cardiovascular conditions.
Warning signs of heart failure may include:
Contact your healthcare provider immediately if you experience rapid weight gain, new or worsening swelling, or increased shortness of breath.
Seek emergency medical attention if you develop severe breathing difficulties, chest pain, or fainting.
Duetact may affect liver function, particularly because it contains pioglitazone.
Although serious liver injury is uncommon, cases of liver problems have been reported in people taking pioglitazone-containing medications.
Your healthcare provider may recommend blood tests to assess your liver function before starting treatment. Additional testing may be necessary if you develop symptoms suggesting liver problems.
Tell your healthcare provider if you have a history of hepatitis, cirrhosis, elevated liver enzymes, or other liver conditions.
Possible signs of liver problems include:
Stop taking Duetact and seek prompt medical advice if you develop symptoms of liver injury.
Your healthcare provider may order blood tests and determine whether treatment should be discontinued.
Pioglitazone, one of the active ingredients in Duetact, has been associated with a possible increased risk of bladder cancer.
Research findings have been mixed, and the relationship between pioglitazone and bladder cancer remains uncertain. However, the potential risk is an important consideration when deciding whether Duetact is appropriate.
Duetact should not be used in patients with active bladder cancer. If you have a history of bladder cancer, your healthcare provider will carefully consider the potential risks and benefits before recommending treatment.
Tell your healthcare provider if you have previously been diagnosed with bladder cancer or have unexplained urinary symptoms.
Possible warning signs include:
Contact your healthcare provider promptly if you notice blood in your urine or develop persistent urinary symptoms.
These symptoms do not necessarily mean you have bladder cancer, but they should be evaluated.
Do not take Duetact if you are allergic to pioglitazone, glimepiride, or any other ingredient in the medication.
Glimepiride belongs to the sulfonylurea class of medications. Tell your healthcare provider if you have previously experienced an allergic reaction to another sulfonylurea.
An allergic reaction may cause itching, hives, a skin rash, swelling, or difficulty breathing.
In rare cases, severe allergic reactions and serious skin reactions may occur.
Stop taking Duetact and contact your healthcare provider if you develop a new rash, unusual swelling, or other signs of an allergic reaction.
Seek emergency medical attention immediately if you experience difficulty breathing, swelling of your face, lips, tongue, or throat, or a severe skin reaction involving blistering or peeling.
Duetact may cause fluid retention because it contains pioglitazone.
Fluid retention occurs when excess fluid builds up in your body’s tissues, often causing swelling in your feet, ankles, or lower legs.
Some people may also experience weight gain while taking Duetact.
Although mild swelling may occur, significant fluid retention can place additional strain on your heart and may worsen existing heart failure.
Contact your healthcare provider if you notice:
Your healthcare provider may recommend monitoring your weight regularly, particularly when you first begin treatment or after a dose increase.
Do not ignore rapid weight gain or swelling accompanied by breathing difficulties, as these may be signs of a serious complication.
Long-term use of pioglitazone-containing medications may increase the risk of bone fractures, particularly in women.
Pioglitazone may affect bone strength over time, making certain bones more likely to fracture.
Fractures may occur in areas such as the hands, wrists, feet, or other parts of the body.
Tell your healthcare provider if you have a history of fractures, low bone density, or osteoporosis.
Your healthcare provider may assess your bone health and recommend appropriate steps to reduce your fracture risk.
These may include weight-bearing exercise, adequate calcium and vitamin D intake, and bone density testing when appropriate.
Contact your healthcare provider if you experience unexplained bone pain, develop a fracture after a minor injury, or have concerns about your bone health.
Duetact may occasionally cause changes in vision.
Pioglitazone has been associated with macular edema, a condition in which fluid builds up in the macula, the part of your eye responsible for sharp central vision.
Macular edema may cause blurred vision, reduced visual clarity, or difficulty seeing fine details.
Changes in blood sugar levels can also temporarily affect your eyesight.
Tell your healthcare provider if you experience:
Contact your healthcare provider promptly if you develop new vision problems. Sudden or severe vision loss requires urgent medical evaluation.
Regular diabetic eye examinations are important even if you do not notice any symptoms, because diabetes can damage your eyes without causing early warning signs.
If you are pregnant, planning to become pregnant, or think you might be pregnant, speak with your healthcare provider before taking Duetact.
Duetact is generally not recommended during pregnancy because there is limited information about its safety for developing babies.
Glimepiride, one of the active ingredients, may cause low blood sugar in newborns if it is taken close to delivery. Poorly controlled diabetes during pregnancy can also increase the risk of complications for both the mother and baby.
Your healthcare provider may recommend insulin or another treatment with more established safety information during pregnancy.
If you become pregnant while taking Duetact, contact your healthcare provider promptly. Do not change or stop your diabetes treatment without medical advice, as uncontrolled blood sugar can also be harmful.
Duetact is not recommended while breastfeeding because it is not known whether pioglitazone or glimepiride passes into human breast milk in clinically significant amounts.
There is concern that exposure to glimepiride could potentially cause low blood sugar in a nursing infant.
If you are breastfeeding or planning to breastfeed, tell your healthcare provider before starting Duetact.
They can help you choose an appropriate diabetes treatment that supports your health while reducing potential risks to your baby.
Do not continue Duetact while breastfeeding without discussing the risks and alternatives with your healthcare provider.
Duetact may interact with certain medications, potentially affecting blood sugar control or increasing the risk of side effects.
Before starting treatment, tell your healthcare provider or pharmacist about all medications you take, including prescription drugs, over-the-counter medications, vitamins, herbal supplements, and other diabetes treatments.
Some important interactions include:
Alcohol may also affect your blood sugar unpredictably, particularly because Duetact contains glimepiride. Drinking alcohol without eating enough food may increase your risk of low blood sugar.
Do not start, stop, or change any medication without consulting your healthcare provider.
Contact your healthcare provider if you experience frequent low blood sugar episodes, persistent dizziness, unusual weakness, or blood sugar readings that remain outside your recommended target range.
You should also seek prompt medical advice if you develop rapid weight gain, swelling in your feet or ankles, new or worsening shortness of breath, yellowing of your skin or eyes, blood in your urine, or unexplained vision changes.
Seek emergency medical attention if you experience severe difficulty breathing, chest pain, loss of consciousness, severe hypoglycemia, or signs of a serious allergic reaction.
Always take Duetact exactly as prescribed. Regular blood sugar monitoring, taking your medication with the first main meal of the day, and attending scheduled medical appointments can help improve diabetes management while reducing the risk of complications.
If you forget to take a dose of Duetact, take it as soon as you remember, preferably with food. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at once or double your next dose to make up for a missed tablet. Taking extra medication may increase your risk of low blood sugar (hypoglycemia) and other unwanted side effects. Duetact is usually taken once daily with the first main meal of the day, typically breakfast. Taking it with food and following a consistent schedule can help you remember your medication and reduce the risk of low blood sugar. If you frequently miss doses or are unsure whether to take a forgotten tablet, speak with your healthcare provider or pharmacist for advice.
Duetact may cause low blood sugar, also known as hypoglycemia, because it contains glimepiride, which stimulates your pancreas to release insulin. Low blood sugar may occur if you skip meals, eat less than usual, exercise more than expected, or take Duetact with other blood sugar-lowering medications. Common symptoms include sweating, shakiness, dizziness, sudden hunger, headache, weakness, a fast heartbeat, and difficulty concentrating. If your blood sugar falls below 4.0 mmol/L (70 mg/dL) and you are awake and able to swallow safely, consume approximately 15 grams of fast-acting carbohydrates, such as glucose tablets or 150 mL of regular fruit juice or non-diet soda. Wait 15 minutes, then check your blood sugar again. If it remains below 4.0 mmol/L, consume another 15 grams of fast-acting carbohydrates and recheck after 15 minutes. Once your blood sugar returns to a safer level, eat a snack or meal if your next meal is not soon. Always carry glucose tablets or another fast-acting source of sugar in case your blood sugar drops unexpectedly. Seek emergency medical attention immediately if you experience severe confusion, seizures, loss of consciousness, or difficulty swallowing. Never give food or drink to someone who is unconscious. Because glimepiride may cause prolonged or recurring low blood sugar, additional medical monitoring may be necessary even after your symptoms improve. Contact your healthcare provider if you experience frequent episodes of hypoglycemia. Your medication dosage or diabetes treatment plan may need to be adjusted.
Duetact begins lowering blood sugar after you start treatment, but the time required to experience its full benefits can vary depending on your medical condition, blood sugar levels, and response to the medication. Duetact contains two active ingredients that work differently to control blood sugar. Glimepiride begins working relatively quickly by stimulating your pancreas to release more insulin. Its blood sugar-lowering effects may begin within a few hours after taking a dose. Pioglitazone works more gradually by improving your body’s sensitivity to insulin. This helps your muscles and other tissues use glucose more effectively while reducing the amount of sugar released by your liver. You may notice improvements in your blood sugar readings within the first few days of treatment. However, the full benefits of pioglitazone may take approximately two to three months to develop. Your healthcare provider may recommend regular blood sugar monitoring and periodic HbA1c testing to evaluate how well Duetact is working. An HbA1c test measures your average blood sugar levels over approximately three months and helps determine whether your diabetes treatment is effective. Continue taking Duetact exactly as prescribed, even if you do not notice immediate improvements. If your blood sugar remains consistently above or below your recommended target range, contact your healthcare provider rather than increasing your dose on your own.
Duetact may not be suitable for everyone with liver or kidney problems. If you have a history of either condition, speak with your healthcare provider before starting treatment. Because Duetact contains two active ingredients, your healthcare provider will need to consider how each medication may affect your liver and kidneys. Pioglitazone, one of the active ingredients in Duetact, may affect liver function. Although serious liver injury is rare, cases have been reported in people taking medications containing pioglitazone. Your healthcare provider may recommend liver function tests before starting treatment and additional monitoring if you have a history of liver disease. Be sure to tell your healthcare provider if you have hepatitis, cirrhosis, elevated liver enzymes, or another liver condition. Contact your healthcare provider promptly if you experience symptoms of liver problems, such as yellowing of your skin or eyes, dark urine, persistent nausea, unusual tiredness, loss of appetite, or pain in the upper right side of your abdomen. If you have active liver disease or significantly abnormal liver function tests, your healthcare provider may recommend a different diabetes medication. If you have kidney disease or reduced kidney function, Duetact may increase your risk of low blood sugar (hypoglycemia). This is because glimepiride and its active metabolites may remain in your body longer when your kidneys are not working properly. As a result, people with moderate or severe kidney impairment may experience low blood sugar that lasts longer or occurs more frequently. Your healthcare provider may recommend a lower starting dose of glimepiride and more frequent blood sugar monitoring to reduce this risk. However, because Duetact combines pioglitazone and glimepiride in a single tablet, it may not provide the flexibility needed for certain dose adjustments. In these situations, your healthcare provider may recommend taking the two medications separately or choosing another diabetes treatment. Before starting Duetact, inform your healthcare provider about any kidney problems, abnormal kidney function tests, or previous episodes of severe low blood sugar. This information can help them determine whether the medication is appropriate for your condition. Always take Duetact exactly as prescribed. Regular blood sugar monitoring, liver and kidney function assessments, and follow-up appointments can help ensure that your diabetes treatment remains safe and effective.
| Generic name: | Pioglitazone/Glimepiride |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 15/1mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Duetact (pioglitazone/glimepiride) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Duetact is commonly prescribed in dosages of 15 /1 mg, taken once daily. For a 90-day supply, this means you would order 90 tablets (90 days x 1 tablet per day).
Yes, we sell pioglitazone/glimepiride on our website. You can enjoy low prices when you order through us. To pioglitazone/glimepiride, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Duetact (pioglitazone/glimepiride) to both the United States and Puerto Rico.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Duetact (Pioglitazone/Glimepiride). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Duetact (Pioglitazone/Glimepiride).
REVIEWS